These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4095128)

  • 1. [Quantitative determination and kinetics of dihydralazine in hypertension patients].
    Siegmund W; Zschiesche M; Kallwellis R; Franke G; Schneider T; Sill U; Scherber A; Hüller H
    Pharmazie; 1985 Nov; 40(11):779-81. PubMed ID: 4095128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the acetylator phenotype for the clinical use of dihydralazine.
    Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydralazine therapy and acetylator phenotype.
    Iisalo E; Laine T; Lehtonen A; Sellman R
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The quantitative determination of dihydralazine and selected metabolites in man].
    Schneider T; Siegmund W; Zschiesche M; Kallwellis R
    Pharmazie; 1988 Oct; 43(10):704-6. PubMed ID: 3212018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of dihydralazine with furosemide in hypertonic patients.
    Siegmund W; Kairies M; Franke G; Donner I; Biebler KE
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinetics of dihydralazine].
    Siegmund WS; Huller H; Franke H; Kallwellis R; Lupke A
    Farmakol Toksikol; 1982; 45(3):105-7. PubMed ID: 7095119
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects.
    Waller AR; Chasseaud LF; Taylor T; Darragh A; O'Kelly DA
    Biopharm Drug Dispos; 1979; 1(2):59-64. PubMed ID: 552862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the kinetics and distribution of dihydralazine in pregnancy.
    Franke G; Pietsch P; Schneider T; Siegmund W; Grabow D; Schütz H
    Biol Res Pregnancy Perinatol; 1986; 7(1):30-3. PubMed ID: 3955125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of antipyrine and sulfamethazine in patients recovered from dihydralazine-hepatitis.
    Siegmund W; Franke G; Baumgarten R; Fengler JD; Krüger R; Reichardt R
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):165-9. PubMed ID: 2714917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The quantitative identification of metabolites of dihydralazine in the human].
    Schneider T; Siegmund W; Zschiesche M; Kallwellis R; Scherber A
    Pharmazie; 1988 Jan; 43(1):33-6. PubMed ID: 3375299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic determination of dihydralazine and hydralazine in human plasma and its application to pharmacokinetic studies of dihydralazine.
    Rouan MC; Campestrini J
    J Pharm Sci; 1985 Dec; 74(12):1270-3. PubMed ID: 4087193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of hydralazine in man. Part II: Investigation of features relevant to drug safety.
    Dubois JP; Schmid K; Riess W; Hanson A; Henningsen NC; Andersson OK
    Arzneimittelforschung; 1987 Feb; 37(2):189-93. PubMed ID: 3580022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of oxdralazine and dihydralazine in essential hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza W; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):372-6. PubMed ID: 7030978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
    Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
    Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension].
    Levenson J; Simon A; Achimastos A; Temmar M; Safar M
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
    Gerc V; Numić N
    Med Arh; 1980; 34(1):51-9. PubMed ID: 7007752
    [No Abstract]   [Full Text] [Related]  

  • 17. Steady-state kinetics of sustained-release phenylpropanolamine.
    Lönnerholm G; Grahnén A; Lindström B
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):39-41. PubMed ID: 6698658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dihydralazine-induced acute hepatitis with IgM deficiency].
    Knoblauch M; Cueni B; Spycher M; Schmid M
    Schweiz Med Wochenschr; 1977 May; 107(19):651-6. PubMed ID: 867010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous generation of hydralazine from labile hydralazine hydrazones.
    Clementi WA; McNay JL; Talseth T; Haegele KD; Ludden TM; Musgrave GE
    J Pharmacol Exp Ther; 1982 Jul; 222(1):159-65. PubMed ID: 7086698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.